comparemela.com

Page 26 - Psychiatry News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Prenatal opioid exposure and not associated with increased risk of neuropsychiatric disorders in children

1. In a cohort study in South Korea, prenatal opioid use did not significantly increase the risk of neuropsychiatric disorders in infants. 2. The risk of a neuropsychiatric disorder was increased by long-term opioid use, greater doses, and use during the first trimester. Evidence Rating Level: 2 (Good) Prenatal opioid exposure is generally contraindicated in

Olanzapine/Samidorphan Maintains Mood Disorder Efficacy, Weight and Glycemic Tolerability at 4 Years

Four-year, phase 3 data from APA 2024 show olanzapine/samidorphan provided consistent antipsychotic efficacy and weight-related safety in patients with either schizophrenia or bipolar I disorder.

vimarsana © 2020. All Rights Reserved.